Sign in
4

Changes in Ownership

ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001053369-13-000024

Director disposed of 13,550,136 shares (other)

  • Director acquired 15,946,502 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

NARINE JEENARINE · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2013-03-21 Conversion : show line 1 in the form +15,946,502 29,435,091 I
2013-03-25 Other disposition : show line 2 in the form −13,550,136 $0.04 $500,000 15,884,955 I

Table II: Derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2013-03-21 Conversion : show line 3 in the form Series E Convertible Preferred Stock −387.5 $1,000.00 $387,500 1,800 I
2013-03-25 Other disposition : show line 4 in the form Warrants −6,666,667 2,436,665 I
Loading xslF345X03/primary_doc.xml…